Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

Ratziu V, Harrison SA, Loustaud-Ratti V, Bureau C, Lawitz E, Abdelmalek M, Alkhouri N, Francque S, Girma H, Darteil R, Couchoux H, Wolf M, Sanyal A, Vonderscher J, Scalfaro P.J Hepatol. 2022 Nov 2:S0168-8278(22)03160-9. doi: 10.1016/j.jhep.2022.10.023. Online ahead of print.PMID: 36334688

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?